Dolby Laboratories (DLB) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts DLB Hot Sheet
Price: $62.32 +1.51%
Financial Fact:
Research and development: 59.21M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 59.21M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.92, $0.10 better than the analyst estimate of $0.82. Revenue for the quarter came in at $334.4 million versus the consensus estimate of $332.51 million.
For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c
- Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
